S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017|
|Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®|
|Mylan to manufacture, distribute Gilead Sciences HIV drug|
|U.S. Supreme Court Partially Modifies Standard of Review of Patent Claim Construction and Remands Review of Teva's '808 Patent on Copaxone® to Federal Circuit Court of Appeals|
|Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16|
|Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS|
|Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors|
|Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries|
|Mylan Launches Generic Viramune XR®|
|South African National Department of Health Selects Mylan as a Leading Supplier for 2015/2018 Antiretroviral Tender|
Click above to view more mutual fund data and stats for myl - Mylan Inc.